Skip to content

Clinical trials

Completed Phase 1/2 Non-alcoholic Fatty Liver Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Phase 1/2 Status: Completed Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20091
20102
20152
20161
20181
20195
20203
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Adrian Vella1
Arrowhead Pharmaceuticals1
Bambino Gesù Hospital and Research Institute1
Cellaion SA1
Chuncheon Sacred Heart Hospital1
Crolll Gmbh1
Elif Oral1
Guangdong Raynovent Biotech Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease22
Fatty Liver6
Obesity4
Liver Cirrhosis3
Liver Diseases3
Fibrosis2
Metabolic Diseases2
Cardiovascular Diseases1
Diabetes Mellitus1
Hypertriglyceridemia1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.